ITRM970390A0 - - Google Patents

Info

Publication number
ITRM970390A0
ITRM970390A0 ITRM970390A ITRM970390A ITRM970390A0 IT RM970390 A0 ITRM970390 A0 IT RM970390A0 IT RM970390 A ITRM970390 A IT RM970390A IT RM970390 A ITRM970390 A IT RM970390A IT RM970390 A0 ITRM970390 A0 IT RM970390A0
Authority
IT
Italy
Application number
ITRM970390A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITRM970390A0 publication Critical patent/ITRM970390A0/it
Priority to IT97RM000390A priority Critical patent/IT1293067B1/it
Priority to US09/446,806 priority patent/US6180680B1/en
Priority to CA002295748A priority patent/CA2295748A1/en
Priority to EP05105620A priority patent/EP1623708A3/en
Priority to IL13349298A priority patent/IL133492A/en
Priority to KR10-1999-7012633A priority patent/KR100539066B1/ko
Priority to JP50684499A priority patent/JP2002507223A/ja
Priority to PCT/IT1998/000163 priority patent/WO1999001126A1/en
Priority to EP98929631A priority patent/EP0983066A1/en
Priority to AU79310/98A priority patent/AU726822B2/en
Priority to NZ501844A priority patent/NZ501844A/en
Publication of ITRM970390A1 publication Critical patent/ITRM970390A1/it
Application granted granted Critical
Publication of IT1293067B1 publication Critical patent/IT1293067B1/it
Priority to US10/928,156 priority patent/US20050026846A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT97RM000390A 1997-01-07 1997-07-01 Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico IT1293067B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT97RM000390A IT1293067B1 (it) 1997-07-01 1997-07-01 Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
JP50684499A JP2002507223A (ja) 1997-07-01 1998-06-18 脂質代謝異常によりもたらされる疾患の治療のための、アルカノイルl−カルニチンをスタチンと組み合わせて含む医薬組成物
EP98929631A EP0983066A1 (en) 1997-07-01 1998-06-18 Pharmaceutical composition comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
EP05105620A EP1623708A3 (en) 1997-07-01 1998-06-18 Pharmaceutical composition comprising acetyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
IL13349298A IL133492A (en) 1997-07-01 1998-06-18 Pharmaceutical preparations containing alkanol L - carnitine in combination with a statin for the treatment of diseases caused by a change in lipid metabolism
KR10-1999-7012633A KR100539066B1 (ko) 1997-07-01 1998-06-18 비정상적 지질대사-유래 질환치료에 유용한 스타틴과알카노일 l-카르니틴 함유 약제 조성물
US09/446,806 US6180680B1 (en) 1997-07-01 1998-06-18 Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
PCT/IT1998/000163 WO1999001126A1 (en) 1997-07-01 1998-06-18 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
CA002295748A CA2295748A1 (en) 1997-07-01 1998-06-18 Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
AU79310/98A AU726822B2 (en) 1997-07-01 1998-06-18 Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
NZ501844A NZ501844A (en) 1997-07-01 1998-06-18 Alkanoyl L-carnitine in combination with a statin (simvastatin, lovastatin, provastatin or fluvastatin) for treating abnormal lipid metabolism disorders
US10/928,156 US20050026846A1 (en) 1997-01-07 2004-08-30 Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000390A IT1293067B1 (it) 1997-07-01 1997-07-01 Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico

Publications (3)

Publication Number Publication Date
ITRM970390A0 true ITRM970390A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-07-01
ITRM970390A1 ITRM970390A1 (it) 1999-01-01
IT1293067B1 IT1293067B1 (it) 1999-02-11

Family

ID=11405149

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000390A IT1293067B1 (it) 1997-01-07 1997-07-01 Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico

Country Status (10)

Country Link
US (2) US6180680B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP1623708A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2002507223A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100539066B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU726822B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2295748A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL133492A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1293067B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ501844A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999001126A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245800B1 (en) * 1999-06-08 2001-06-12 Sigma-Tau Method of preventing or treating statin-induced toxic effects using L-carnitine or an alkanoyl L-carnitine
HUP0201597A3 (en) * 1999-06-08 2003-04-28 Sigma Tau Ind Farmaceutiche S Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines
DE69923670T2 (de) * 1999-06-30 2006-03-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Lipidsenkende Kombination, die im wesentlichen frei ist von toxischen Wirkungen und Nebenwirkungen der Lipidsenker
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040307A1 (it) 2004-06-23 2004-09-23 Sigma Tau Ind Farmaceuti Confezione per almeno due prodotti differenti da vendere e utilizzare insieme.
SG177993A1 (en) * 2007-02-27 2012-02-28 Sigma Tau Ind Farmaceuti Composition useful for the treatment of type 2 diabetes
DK2136798T3 (en) 2007-03-21 2015-08-31 Sigma Tau Ind Farmaceuti Compositions useful in the prevention of type 2 diabetes and complications associated therewith in pre-diabetic patients with insulin resistance
RU2329051C1 (ru) * 2007-04-02 2008-07-20 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Композиция, обладающая гиполипидемической и гепатопротекторной активностью
CA2716020C (en) 2008-02-29 2018-10-16 Biolab Sanus Farmaceutica Ltda. Pharmaceutical compositions comprising piracetam and l-carnitine
CN111194307A (zh) * 2017-08-23 2020-05-22 嘉维什-嘉利理生物应用有限公司 用于治疗动脉粥样硬化性心血管疾病的组合物和方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel

Also Published As

Publication number Publication date
IL133492A0 (en) 2001-04-30
KR100539066B1 (ko) 2005-12-26
US20050026846A1 (en) 2005-02-03
KR20010014439A (ko) 2001-02-26
AU7931098A (en) 1999-01-25
ITRM970390A1 (it) 1999-01-01
EP1623708A3 (en) 2006-02-15
US6180680B1 (en) 2001-01-30
CA2295748A1 (en) 1999-01-14
WO1999001126A1 (en) 1999-01-14
NZ501844A (en) 2001-10-26
EP0983066A1 (en) 2000-03-08
EP1623708A2 (en) 2006-02-08
AU726822B2 (en) 2000-11-23
IT1293067B1 (it) 1999-02-11
IL133492A (en) 2004-07-25
JP2002507223A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
FR04C0013I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2001527349A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN190655B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITRM970390A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI971235A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970494A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI971094A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITPD970129A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI971095A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB9708552D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN182481B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITPS970017V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN189551B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN186120B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITRM970398A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITRM970436A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970343A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITTO970453A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMC970008V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITVR970014V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3058449S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3055603S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3057976S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3057730S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN3057614S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
0001 Granted